3 Trends Shaping The Future Of Biomanufacturing
Insights from Expert Marius Müller, PhD, Team Lead at Johnson & Johnson Innovative Medicine

In the highly competitive biopharma and biomanufacturing industries, optimizing processes, reducing risks, and enhancing product quality are constant priorities. Technological advancements are key enablers in achieving these goals. According to Marius Müller, PhD, Team Lead at Johnson & Johnson Innovative Medicine, three major trends are set to make a significant impact. These include the sophisticated use of data science and AI-powered digital twins for process simulation, increased hardware and software automation reducing manual tasks in analytical labs, and the adoption of Process Analytical Technologies (PAT) for immediate, on-line data analysis.
These innovations promise a future of streamlined operations. Discover the specifics of these transformative developments. Read the full breakdown below.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.